0001968582-23-000490.txt : 20230911 0001968582-23-000490.hdr.sgml : 20230911 20230911091543 ACCESSION NUMBER: 0001968582-23-000490 CONFORMED SUBMISSION TYPE: 144/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20230911 DATE AS OF CHANGE: 20230911 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Ascendis Pharma A/S CENTRAL INDEX KEY: 0001612042 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: G7 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 144/A SEC ACT: 1933 Act SEC FILE NUMBER: 001-36815 FILM NUMBER: 231246954 BUSINESS ADDRESS: STREET 1: TUBORG BOULEVARD 12 CITY: HELLERUP STATE: G7 ZIP: DK-2900 BUSINESS PHONE: 45 70 22 22 44 MAIL ADDRESS: STREET 1: TUBORG BOULEVARD 12 CITY: HELLERUP STATE: G7 ZIP: DK-2900 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: MIKKELSEN JAN MOLLER CENTRAL INDEX KEY: 0001180765 FILING VALUES: FORM TYPE: 144/A MAIL ADDRESS: STREET 1: 515 GALVESTON DR CITY: REDWOOD CITY STATE: CA ZIP: 94063 144/A 1 primary_doc.xml 144/A 0001968582-23-000489 0001180765 XXXXXXXX LIVE 0001612042 Ascendis Pharma A/S 001-36815 Tuborg Boulevard 12 Hellerup Denmark G7 DK - 2900 45-7022-2244 Jan Moller Mikkelsen Affiliate ADS J.P. Morgan Securities LLC

390 Madison Avenue 6th Floor New York NY 10017

66755 6513952 57152295 09/08/2023 Nasdaq ADS 09/08/2023 Warrant Exercise Issuer N 66755 09/08/2023 Cash Y The shares on this filing will be acquired via warrant exercises during month of Sept 2023. Sales represent shares to be sold to cover tax obligations and the payment of the exercise price on warrants exercised, which were due to expire in Q3, 2023. 09/11/2023 /s/ J.P. Morgan Securities LLC as agent and attorney-in-fact for Jan Mikkelsen